AdaptHealth (NasdaqCM:AHCO) 2026 Conference Transcript

AdaptHealth Conference Call Summary Company Overview - Company: AdaptHealth (NasdaqCM: AHCO) - Industry: Sleep Apnea and Respiratory Equipment Key Points Sleep Apnea Market Insights - Approximately 33-34 million Americans suffer from obstructive sleep apnea (OSA), with only 20% diagnosed and treated, indicating a significant underdiagnosed population [2][38] - The market is expected to grow at a rate of low to mid-single digits annually [40] - AdaptHealth holds about 25% of the U.S. CPAP market, significantly larger than any competitor [41] Patient Adherence and Revenue Model - AdaptHealth reports an adherence rate of over 80%, compared to the industry average of just over 70% [9][7] - The company receives approximately $60 per month from Medicare for CPAP rentals over a 13-month period, with an average resupply order costing about $200 [25][11] - Patients are typically resupplied just under three times a year, compared to the industry average of two times [11] Operational Efficiency - The average setup time for patients has improved from 17 days to 9 days, enhancing patient satisfaction and referral rates [35] - AdaptHealth employs 700 sales representatives to maintain relationships with referring physicians, ensuring a steady flow of patient referrals [33] Growth Strategies - The company is expanding its presence on the West Coast with 30 new locations and an acquisition in Hawaii, aiming to capture more market share in previously underserved areas [42][43] - AdaptHealth is actively pursuing additional capitated contracts, with a dedicated team working on pricing and competitive bids [114] Regulatory Environment - The CMS has increased the fee schedule by just over 2% for 2026, which is beneficial for the industry [105] - The SOAR Act is being lobbied to increase reimbursement levels for respiratory services, which is a significant category for AdaptHealth [109] Competitive Landscape - AdaptHealth has not seen any impact from competitors claiming preferred status with payers, maintaining stable referral patterns [95][96] - The company views competitive bidding as an opportunity for consolidation and market share growth, especially in the CGM distribution segment [91][92] Financial Performance - Adjusted EBITDA margins for sleep and respiratory segments run in the high 20% range, with gross margins around 60% for resupply costs [118][119] Challenges and Opportunities - The transition of patients from incumbent providers is complex, but AdaptHealth is leveraging lessons learned from previous contracts to streamline this process [68] - The company is focused on enhancing its core offerings rather than diversifying into new product lines, given the significant growth potential within existing markets [113] Additional Insights - AdaptHealth's proactive approach to patient adherence and operational efficiency positions it well for future growth in the sleep apnea and respiratory equipment markets [6][20] - The company is committed to maintaining high patient satisfaction to ensure continued referrals from healthcare providers [34][122]